04/05/2010
ReGen Therapeutics Plc (“ReGen” or the “Company”), (AIM:RGT) is pleased to announce that it has conditionally placed 11,550,000 new ordinary shares at 2p per ordinary share to raise £231,000 before expenses for general working capital purposes.
The 11,550,000 new ordinary shares, which will represent 18.75 per cent of the enlarged issued share capital of the Company (in aggregate amounting to 61,613,215 ordinary shares on completion of the placing), will rank pari passu in all respects with the existing ordinary shares in the Company.
Application has been made to the London Stock Exchange for the new ordinary shares to be admitted to trading on AIM and admission is expected to commence on or around Monday 10 May 2010.
For further information, please contact:
Percy Lomax
ReGen Therapeutics Plc
Tel: 020 7153 4920
Roland Cornish/Felicity Geidt
Beaumont Cornish Limited
Tel: 020 7628 3396
David Scott/Nick Bealer
Alexander David Securities Limited
Tel: 020 7448 9820